CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
May 16, 2019—Siemens Healthineers announced the worldwide availability of its Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes.
“Laboratories are seeking HbA1c assays that can be integrated onto chemistry testing platforms and that provide the accurate and precise results patients deserve,” Deepak Nath, PhD, president of laboratory diagnostics, Siemens Healthineers, said in a press release. “The new Atellica CH Enzymatic Hemoglobin A1c Assay offers these capabilities.”
Pages: 1 2